PYC 4.00% 13.0¢ pyc therapeutics limited

Ann: Conclusion of Genentech Antimicrobial Collaboration, page-3

  1. 5,298 Posts.
    lightbulb Created with Sketch. 683
    Similar to what i thought about previous announcements. They are now clear and direct. The collaboration ended and so they tell us. Previously this would go unmentioned for another two years then be reffered to as a deal with a major pharma for even longer even though finished. Strange it took 5 years for genentech to find we could change color of bacteria but not kill it.

    In the end after the focus on eye no pun intended i guess this no longer matters. Strange as it seems this initially boosted us from 1c to 5c level? Eye has taken us hopefully from 5c resistance to 5c support and up
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.